cobaltous chloride has been researched along with metformin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Borin, TF; Carvalho, LGS; de Campos Zuccari, DAP; Ferreira, LC; Gelaleti, GB; Hellmén, E; Jardim-Perassi, BV; Leonel, C; Maschio-Signorini, LB; Moschetta, MG; Sonehara, NM | 1 |
Andreadou, I; Dimopoulos, MA; Doerschmann, H; Efentakis, P; Kastritis, E; Nikolaou, PE; Siemer, S; Stauber, R; Terpos, E; Wenzel, P; Witzler, C | 1 |
2 other study(ies) available for cobaltous chloride and metformin
Article | Year |
---|---|
Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.
Topics: Animals; Cell Line, Tumor; Chromones; Cobalt; Dog Diseases; Dogs; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Animal; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Morpholines; Neovascularization, Pathologic; Oxygen; Vascular Endothelial Growth Factor A | 2019 |
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.
Topics: Actins; AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Survival; Cobalt; Dinoprost; Drug Therapy, Combination; Endoplasmic Reticulum; Glucose; Glycolysis; Humans; Male; Metformin; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Nitric Oxide; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinases; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2020 |